Eli Harriss

Datos Biográficos

ID9069374
NOMBREEli Harriss
NOMBRESEli
APELLIDOHarriss
FIRMAHARRISS E
AFILIACIONESBodleian Health Care Libraries, University of Oxford, Oxford, UK
ORCID0000-0003-4635-8959
VERIFICADOSí
TOTAL DE OBRAS5
TOTAL DE CITAS0
OBRAS COMO AUTOR5
OBRAS COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Systematic scoping review of the noma evidence landscape

    Open AccessBrittany J Maguire, Rujan Shrestha et al.ARTICLEBMJ Global Health2025

    BACKGROUND: Noma (cancrum oris) is a severe gangrenous disease of the mouth and oro-facial structures. Noma often affects young children living in extreme poverty, malnutrition and poor sanitation. Gaps remain in understanding its aetiology, pathogenesis, prevention and treatment. METHODS AND FINDINGS: We systematically searched databases for all primary research studies (clinical trials, cohort studies, case-control, cross-sectional, other obser…

  • Expanded roles of community health workers beyond malaria in the Asia-Pacific

    Open AccessMonnaphat Jongdeepaisal, Panarasri Khonputsa et al.ARTICLEPLOS Global Public Health2024

    In the Greater Mekong Subregion (GMS), community health workers (CHWs) are a key component of malaria elimination strategies. As malaria declines, support for, and uptake of, malaria services may also subsequently decrease. Expanding their roles beyond malaria has been proposed to sustain the services. A systematic review was conducted to identify and characterize programmes with CHWs providing services in addition to those for malaria in the Asi…

  • Characterisation of populations at risk of sub-optimal dosing of artemisinin-based combination therapy in Africa

    Open AccessAbena Takyi, Verena I Carrara et al.ARTICLEPLOS Global Public Health2023

    Selection of resistant malaria strains occurs when parasites are exposed to inadequate antimalarial drug concentrations. The proportion of uncomplicated falciparum malaria patients at risk of being sub-optimally dosed with the current World Health Organization (WHO) recommended artemisinin-based combination therapies (ACTs) is unknown. This study aims to estimate this proportion and the excess number of treatment failures (recrudescences) associa…

  • Availability, scope and quality of monkeypox clinical management guidelines globally

    Open AccessEika Webb, Ishmeala Rigby et al.ARTICLEBMJ Global Health2022

  • Characterising long Covid

    Open AccessMelina Michelen, Lakshmi Manoharan et al.ARTICLEBMJ Global Health2021